For a full list of ZhengLab's publication, pleace click Google Scholar |PubMed.




    2022

  1. Xiao C, Wang JT, Su C, Miao Z, Tang J, Ouyang Y, Yan Y, Jiang Z, Fu Y, Shuai M, Gou W, Xu F, Yu EY, Liang Y, Liang X, Tian Y, Wang J, Huang F, Zhang B, Wang H, Chen YM*, Zheng JS*. Associations of dietary diversity with the gut microbiome, fecal metabolites, and host metabolism: results from 2 prospective Chinese cohorts. Am J Clin Nutr. 2022 Oct 6;116(4):1049-1058.

  2. Miao Z, Chen GD, Huo S, Fu Y, Wu MY, Xu F, Jiang Z, Tang J, Gou W, Xiao C, Liu YP, Wu YY, Sun TY, Sun L, Shen LR, Lin X, Chen YM*, Zheng JS*. Interaction of n-3 polyunsaturated fatty acids with host CD36 genetic variant for gut microbiome and blood lipids in human cohorts. Clin Nutr. 2022 Aug;41(8):1724-1734.

  3. Tang J, Gou W, Fu Y, Li K, Guo X, Huang T, Liu H*, Li D*, Zheng JS*. Association Between Postterm Pregnancy and Adverse Growth Outcomes in Preschool-Aged Children. Am J Clin Nutr. 2022 Aug 4;116(2):482-490.

  4. Miao Z, Du W, Xiao C, Su C, Gou W, Shen L, Zhang J, Fu Y, Jiang Z, Wang Z, Jia X, Zheng JS*, Wang H*. Gut microbiota signatures of long-term and short-term plant-based dietary pattern and cardiometabolic health: a prospective cohort study. BMC Med. 2022 Jun 15;20(1):204.

  5. Jiang Z, Zhuo LB, He Y, Fu Y, Shen L, Xu F, Gou W, Miao Z, Shuai M, Liang Y, Xiao C, Liang X, Tian Y, Wang J, Tang J, Deng K, Zhou H, Chen YM, Zheng JS*. The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases. Nat Commun. 2022 May 30;13(1):3002.

  6. Deng K, Shuai M, Zhang M, Jiang Z, Fu Y, Shen L, Zheng JS*, Chen YM*. Temporal relationship among adiposity, gut microbiota, and insulin resistance in a longitudinal human cohort. BMC Med. 2022 May 19;20(1):171.

  7. Wang H, Gou W, Su C, Du W, Zhang J, Miao Z, Xiao C, Jiang Z, Wang Z, Fu Y, Jia X, Ouyang Y, Jiang H, Huang F, Li L, Zhang B*, Zheng JS*. Association of gut microbiota with glycaemic traits and incident type 2 diabetes, and modulation by habitual diet: a population-based longitudinal cohort study in Chinese adults. Diabetologia. 2022 Sep;65(9):1572.

  8. Shuai M, Fu Y, Zhong HL, Gou W, Jiang Z, Liang Y, Miao Z, Xu JJ, Huynh T, Wahlqvist ML*, Chen YM*, Zheng JS*. Mapping the human gut mycobiome in middle-aged and elderly adults: multiomics insights and implications for host metabolic health. Gut. 2022 Sep;71(9):1812-1820.

  9. Shuai, M, Zhang G, Zeng F, Fu Y, Liang X, Yuan L, Xu F, Gou W, Miao Z, Jiang Z, Wang J, Zhuo L, Chen YM*,Ju F* Zheng JS*. Human Gut Antibiotic Resistome and Progression of Diabetes. Adv Sci (Weinh). 2022 Apr;9(11):e2104965.

  10. Gou W, Yue L, Tang XY, Wu YY, Cai X, Shuai M, Miao Z, Fu Y, Chen H, Jiang Z, Wang J, Tian Y, Xiao C, Xiang N, Wu Z, Chen YM*, Guo T*, Zheng JS*. Circulating proteome and progression of type 2 diabetes. J Clin Endocrinol Metab. 2022 May 17;107(6):1616-1625.



    2021

  1. Zheng JS*, Ordovás JM. (2021). Precision nutrition for gut microbiome and diabetes research: Application of nutritional n-of-1 clinical trials. J Diabetes, 1753-0407.

  2. Gou W, Fu Y, Yue L, Chen GD, Cai X, Shuai M, Xu F, Yi X, Chen H, Zhu Y, Xiao ML, Jiang Z, Miao Z, Xiao C, Shen B, Wu X, Zhao H, Ling W, Wang J*, Chen YM*, Guo T*, Zheng JS*. (2021). Gut microbiota, inflammation, and molecular signatures of host response to infection. Journal of Genetics and Genomics, 48(9),792-802.

  3. Ma Y, Fu Y, Tian Y, Gou W, Miao Z, Yang M, Ordovás JM, Zheng JS*. (2021). Individual postprandial glycemic responses to diet in n-of-1 trials: Westlake N-of-1 Trials for Macronutrient Intake (WE-MACNUTR). The Journal of nutrition, 151(10), 3158-3167.

  4. Fu Y, Xu F, Jiang L, Miao Z, Liang X, Yang J, Larsson SC, Zheng JS*. (2021). Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study. BMC medicine, 19(1),1-14.

  5. Shuai M, Zuo LS, Miao Z, Gou W, Xu F, Jiang Z, Ling CW, Fu Y, Xiong F, Chen YM*, Zheng JS*. (2021). Multi-omics analyses reveal relationships among dairy consumption, gut microbiota and cardiometabolic health. EBioMedicine, 66,103284.

  6. Gou W, Ling CW, He Y, Jiang Z, Fu Y, Xu F, Miao Z, Sun TY, Lin JS, Zhu HL, Zhou H, Chen YM*, Zheng JS*. (2021). Interpretable machine learning framework reveals robust gut microbiome features associated with type 2 diabetes. Diabetes Care, 44(2),358-366.

  7. Zheng JS, Luan J, Sofianopoulou E, ...(37 co-authors)..., Forouhi NG*, Wareham NJ*. (2021). Plasma Vitamin C and Type 2 Diabetes: Genome-Wide Association Study and Mendelian Randomization Analysis in European Populations. Diabetes Care. 2021 Jan;44(1):98-106.



    2020

  1. Miao Z, Lin JS, Mao Y, Chen GD, Zeng FF, Dong HL, Jiang Z, Wang J, Xiao C, Shuai M, Gou W, Fu Y, Imamura F, Chen YM*, Zheng JS*. (2020). Erythrocyte n-6 polyunsaturated fatty acids, gut microbiota, and incident type 2 diabetes: a prospective cohort study. Diabetes Care, 43(10),2435-2443.

  2. Xu F, Fu Y, Sun TY, Jiang Z, Miao Z, Shuai M, Gou W, Ling CW, Yang J, Wang J*, Chen YM*, Zheng JS*. (2020). The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases. Microbiome, 8(1),1-14.

  3. Jiang Z, Sun TY, He Y, Gou W, Zuo LS, Fu Y, Miao Z, Shuai M, Xu F, Xiao C, Liang Y, Wang J, Xu Y, Jing LP, Ling W, Zhou H*, Chen YM*, Zheng JS*. (2020). Dietary fruit and vegetable intake, gut microbiota, and type 2 diabetes: results from two large human cohort studies. BMC medicine, 18(1),1-11.

  4. Fu Y, Gou W, Hu W, Mao Y, Tian Y, Liang X, Guan Y, Huang T, Li K, Guo X, Liu H*, Li D*, Zheng JS*. (2020). Integration of an interpretable machine learning algorithm to identify early life risk factors of childhood obesity among preterm infants: a prospective birth cohort. BMC medicine, 18(1),1-10.

  5. Zheng JS*, Luan J, Sofianopoulou E, ...(45 co-authors)..., Forouhi NG*, Wareham NJ*. (2020). The association between circulating 25-hydroxyvitamin D metabolites and type 2 diabetes in European populations: a meta-analysis and Mendelian randomisation analysis. PLoS medicine, 17(10),e1003394.

  6. Zheng JS*, Wahlqvist ML. (2020). Regulobiosis: A regulatory and food system-sensitive role for fungal symbionts in human evolution and ecobiology. Asia Pacific Journal of Clinical Nutrition, 29(1),9-15.

  7. Zheng JS, Sharp SJ, Imamura F, ...(40 co-authors)..., Forouhi NG*, Wareham NJ. (2020). Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countries. BMJ, 370.

  8. Tang J, Wan Y, Zhao M, Zhong H, Zheng JS*, Feng F*. (2020). Legume and soy intake and risk of type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. The American journal of clinical nutrition, 111(3), 677-688.

  9. Tian Y, Ma Y, Fu Y, Zheng JS*. (2020). Application of n-of-1 Clinical Trials in Personalized Nutrition Research: A Trial Protocol for Westlake N-of-1 Trials for Macronutrient Intake (WE-MACNUTR). Current Developments in Nutrition, 4(9),nzaa143.



    Before 2019

  1. Zheng JS*, Imamura F, Sharp SJ, Koulman A, Griffin JL, Mulligan AA, Luben R, Khaw KT, Wareham NJ, Forouhi NG*. (2019). Changes in plasma phospholipid fatty acid profiles over 13 years and correlates of change: European Prospective Investigation into Cancer and Nutrition-Norfolk Study. The American journal of clinical nutrition, 109(6),1527-1534.

  2. Zheng JS*, Imamura F, Sharp SJ, ...(34 co-authors)..., Forouhi NG*, Wareham NJ. (2019). Association of plasma vitamin D metabolites with incident type 2 diabetes: EPIC-InterAct case-cohort study. The Journal of Clinical Endocrinology & Metabolism, 104(4),1293-1303.

  3. Zheng JS*, Lin JS, Dong HL, Zeng FF, Li D, Song Y, Chen YM*. (2019). Association of erythrocyte n-3 polyunsaturated fatty acids with incident type 2 diabetes in a Chinese population. Clinical Nutrition, 38(5),2195-2201.

  4. Zheng JS*, Chen J, Wang L, Yang H, Fang L, Yu Y, Yuan L, Feng J, Li K, Tang J, Lin M, Lai CQ, Li D*. (2018). Replication of a gene-diet interaction at CD36, NOS3 and PPARG in response to omega-3 fatty acid supplements on blood lipids: a double-blind randomized controlled trial. EBioMedicine, 31,150-156.